Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
R. Gacesa, A. Vich Vila, V. Collij, Z. Mujagic, A. Kurilshikov, M.D. Voskuil, E.A.M. Festen, C. Wijmenga, D.M.A.E. Jonkers, G. Dijkstra, J. Fu, A. Zhernakova, F. Imhann & R.K. Weersma. (2021) A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes 13:1.
Read now
Read now
Ewelina Motylewska, Joanna Gawronska, Agata Niedziela, Gabriela Melen-Mucha, Hanna Lawnicka, Jan Komorowski, Jacek Swietoslawski & Henryk Stepien. (2016) Somatostatin Analogs and Tumor Localization Do Not Influence Vitamin D Concentration in Patients with Neuroendocrine Tumors. Nutrition and Cancer 68:3, pages 428-434.
Read now
Read now
Miral R Sadaria, Ralph H Hruban & Barish H Edil. (2013) Advancements in pancreatic neuroendocrine tumors. Expert Review of Gastroenterology & Hepatology 7:5, pages 477-490.
Read now
Read now
Articles from other publishers (41)
Soo In Choi. (2022) Diagnosis and Treatment of Gastric Neuroendocrine Tumors. Journal of Digestive Cancer Research 10:1, pages 1-8.
Crossref
Crossref
Alessandro Ottaiano, Mariachiara Santorsola, Francesco Perri, Ugo Pace, Bruno Marra, Marco Correra, Francesco Sabbatino, Marco Cascella, Nadia Petrillo, Monica Ianniello, Marika Casillo, Gabriella Misso, Paolo Delrio, Michele Caraglia & Guglielmo Nasti. (2022) Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum. Biology 11:2, pages 267.
Crossref
Crossref
Sean Alexander Bennett, Calvin How Lim Law, Angela Assal, Sten Myrehaug & Julie Hallet. 2021. Neuroendocrine Tumors. Neuroendocrine Tumors
137
156
.
N. V. Lyubimova, Yu. S. Timofeev, T. K. Churikova, A. A. Markovich, G. S. Emelianova, I. S. Stilidi & N. E. Kushlinskii. (2020) Chromogranin A and serotonin for evaluation of treatment efficacy of neuroendocrine tumors. Almanac of Clinical Medicine 47:8, pages 685-690.
Crossref
Crossref
Joanna Gotfrit & Timothy Asmis. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
658
666
.
Huamin Zhai, Duguang Li, Qingbo Feng, Xiaowei Qian, Ling Li & Jie Yao. (2019) Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database. International Journal of Surgery 66, pages 103-109.
Crossref
Crossref
Seyedehnafiseh Mirniaharikandehei, Joshua VanOsdol, Morteza Heidari, Gopichandh Danala, Sri Nandhini Sethuraman, Ashish Ranjan & Bin Zheng. (2019) Developing a Quantitative Ultrasound Image Feature Analysis Scheme to Assess Tumor Treatment Efficacy Using a Mouse Model. Scientific Reports 9:1.
Crossref
Crossref
Marianne E. Pavel, Alexandria T. Phan, Edward M. Wolin, Beloo Mirakhur, Nilani Liyanage, Susan Pitman Lowenthal, George A. FisherJrJr & Aaron I. Vinik. (2019) Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. The Oncologist 24:4, pages 463-474.
Crossref
Crossref
Joshua Vanosdol, Gopichandh Danala, Morteza Heidari, Ashish Ranjan, Bin Zheng & Seyedeh-Nafiseh Mirnia-harikandehei. (2019) Developing a quantitative ultrasound image feature analysis scheme to assess tumor treatment efficacy using a mouse model. Developing a quantitative ultrasound image feature analysis scheme to assess tumor treatment efficacy using a mouse model.
Michele A. Riordon & Calvin H. L. Law. 2019. Clinical Algorithms in General Surgery. Clinical Algorithms in General Surgery
185
190
.
Giuseppe Nigri, Niccolò Petrucciani, Tarek Debs, Livia Maria Mangogna, Anna Crovetto, Giovanni Moschetta, Raffaello Persechino, Paolo Aurello & Giovanni Ramacciato. (2018) Treatment options for PNET liver metastases: a systematic review. World Journal of Surgical Oncology 16:1.
Crossref
Crossref
Yi Wang, Kun Huang, Jie Chen, Yanji Luo, Yu Zhang, Yingmei Jia, Ling Xu, Minhu Chen, Bingsheng Huang, Dong Ni, Zi-Ping Li & Shi-Ting Feng. (2018) Combined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis. Contrast Media & Molecular Imaging 2018, pages 1-10.
Crossref
Crossref
Małgorzata Fuksiewicz, Maria Kowalska, Agnieszka Kolasińska-Ćwikła, Jarosław B Ćwikła, Łukasz Sawicki, Katarzyna Roszkowska-Purska, Joanna Drygiel & Beata Kotowicz. (2018) Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine. Endocrine Connections 7:6, pages 803-810.
Crossref
Crossref
S Shao, Z Zeng & S Hu. (2018) An observational analysis of insulinoma from a single institution. QJM: An International Journal of Medicine 111:4, pages 237-241.
Crossref
Crossref
Yang Lv, Xu Han, Chunyan Zhang, Yuan Fang, Ning Pu, Yuan Ji, Dansong Wang, Xu Xuefeng & Wenhui Lou. (2018) Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs. Endocrine Connections 7:1, pages 169-178.
Crossref
Crossref
Dong Wook Lee, Michelle Kang Kim & Ho Gak Kim. (2017) Diagnosis of Pancreatic Neuroendocrine Tumors. Clinical Endoscopy 50:6, pages 537-545.
Crossref
Crossref
P. Pérez-Albert, T. de Rojas, M. Á. Lendínez, L. Illade, M. García-Abos, J. Alonso-Cadenas, M. Andión & L. Madero. (2017) Management and outcome of children with neuroendocrine tumors of the appendix in Spain: Is there room for improvement?. Clinical and Translational Oncology 19:9, pages 1168-1172.
Crossref
Crossref
Tetsuhide Ito, Susumu Hijioka, Toshihiko Masui, Atsuko Kasajima, Yuji Nakamoto, Noritoshi Kobayashi, Izumi Komoto, Masayuki Hijioka, Lingaku Lee, Hisato Igarashi, Robert Thomas Jensen & Masayuki Imamura. (2016) Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan. Journal of Gastroenterology 52:1, pages 9-18.
Crossref
Crossref
Ganesan Padmavathi, Devivasha Bordoloi, Kishore Banik & Ajaikumar B. Kunnumakkara. 2017. Next Generation Point-of-care Biomedical Sensors Technologies for Cancer Diagnosis. Next Generation Point-of-care Biomedical Sensors Technologies for Cancer Diagnosis
1
29
.
N. V. Lyubimova & N. E. Kushlinskii. (2016) BIOCHEMICAL MARKERS IN SERUM AND URINE IN THE WORKUP OF PATIENTS WITH NEUROENDOCRINE TUMORS. Almanac of Clinical Medicine 44:4, pages 439-450.
Crossref
Crossref
Yugang Cheng, Hanxiang Zhan, Lei Wang, Jianwei Xu, Guangyong Zhang, Zongli Zhang & Sanyuan Hu. (2016) Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes. Frontiers of Medicine 10:4, pages 444-450.
Crossref
Crossref
Tiantian Tian, Jing Gao, Na Li, Yanyan Li, Ming Lu, Zhongwu Li, Zhihao Lu, Jie Li & Lin Shen. (2016) Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors. PLOS ONE 11:5, pages e0154679.
Crossref
Crossref
A. Viúdez, A. De Jesus-Acosta, F.L. Carvalho, R. Vera, S. Martín-Algarra & N. Ramírez. (2016) Pancreatic neuroendocrine tumors: Challenges in an underestimated disease. Critical Reviews in Oncology/Hematology 101, pages 193-206.
Crossref
Crossref
N. V. Lyubimova, T. K. Churikova & N. E. Kushlinskii. (2016) Chromogranin As a Biochemical Marker of Neuroendocrine Tumors. Bulletin of Experimental Biology and Medicine 160:5, pages 702-704.
Crossref
Crossref
Alessandro Paniccia, Barish H. Edil & Richard D. Schulick. (2015) Pancreatic Neuroendocrine Tumors: an Update. Indian Journal of Surgery 77:5, pages 395-402.
Crossref
Crossref
Simron Singh, Chris Dey, Hagen Kennecke, Walter Kocha, Jean Maroun, Peter Metrakos, Tariq Mukhtar, Janice Pasieka, Daniel Rayson, Corwyn Rowsell, Lucas Sideris, Ralph Wong & Calvin Law. (2014) Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group. Annals of Surgical Oncology 22:8, pages 2685-2699.
Crossref
Crossref
Thorvardur R Halfdanarson, James R Howe, Sigurdis Haraldsdottir & Thomas M O'Dorisio. (2015) Circulating tumor markers in patients with neuroendocrine tumors – a clinical perspective. International Journal of Endocrine Oncology 2:1, pages 89-99.
Crossref
Crossref
Xin-Wei Qiao, Ling Qiu, Yuan-Jia Chen, Chang-Ting Meng, Zhao Sun, Chun-Mei Bai, Da-Chun Zhao, Tai-Ping Zhang, Yu-Pei Zhao, Yu-Li Song, Yu-Hong Wang, Jie Chen & Chong-Mei Lu. (2014) Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas. BMC Endocrine Disorders 14:1.
Crossref
Crossref
Masayuki Hijioka, Tetsuhide Ito, Hisato Igarashi, Nao Fujimori, Lingaku Lee, Taichi Nakamura, Robert T. Jensen & Ryoichi Takayanagi. (2014) Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors. Cancer Science 105:11, pages 1464-1471.
Crossref
Crossref
Franco Grimaldi, Nicola Fazio, Roberto Attanasio, Andrea Frasoldati, Enrico Papini, Francesco Angelini, Roberto Baldelli, Debora Berretti, Sara Bianchetti, Giancarlo Bizzarri, Marco Caputo, Roberto Castello, Nadia Cremonini, Anna Crescenzi, Maria Vittoria Davì, Angela Valentina D’Elia, Antongiulio Faggiano, Stefano Pizzolitto, Annibale Versari, Michele Zini, Guido Rindi & Kjell Öberg. (2014) Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Journal of Endocrinological Investigation 37:9, pages 875-909.
Crossref
Crossref
Dimitrios Karakaxas, Maria Gazouli, Theodoros Liakakos, Anna Vaiopoulou, Dimitra Apessou, Kleo Papaparaskeva, Pavlos Patapis & Christos Dervenis. (2014) Pancreatic neuroendocrine tumors. European Journal of Gastroenterology & Hepatology 26:8, pages 826-835.
Crossref
Crossref
Sara Massironi, Roberta Elisa Rossi, Giovanni Casazza, Dario Conte, Clorinda Ciafardini, Marianna Galeazzi & Maddalena Peracchi. (2014) Chromogranin A in Diagnosing and Monitoring Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Large Series from a Single Institution. Neuroendocrinology 100:2-3, pages 240-249.
Crossref
Crossref
Maja Cigrovski Berkovic, Tamara Cacev, Tina Catela Ivkovic, Vanja Zjacic-Rotkvic & Sanja Kapitanovic. (2014) New Insights into the Role of Chronic Inflammation and Cytokines in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology 99:2, pages 75-84.
Crossref
Crossref
Dhakshina GaneshanPriya BhosaleThomas YangVikas Kundra. (2013) Imaging Features of Carcinoid Tumors of the Gastrointestinal Tract. American Journal of Roentgenology 201:4, pages 773-786.
Crossref
Crossref
Miklós Tóth. (2013) Medical treatment of neuroendocrine tumours. Orvosi Hetilap 154:39, pages 1556-1564.
Crossref
Crossref
Sapna Rustagi, Richard R.P. Warner & Celia M. Divino. (2013) Serum pancreastatin: The next predictive neuroendocrine tumor marker. Journal of Surgical Oncology 108:2, pages 126-128.
Crossref
Crossref
James C. YaoDiane Reidy LagunesMatthew H. Kulke. (2013) Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned. The Oncologist 18:5, pages 525-532.
Crossref
Crossref
. (2013) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 20:1, pages 74-79.
Crossref
Crossref
Fabio Morandi, Giuliana Cangemi, Sebastiano Barco, Loredana Amoroso, Maria Giuliano, Anna Rita Gigliotti, Vito Pistoia & Maria Valeria Corrias. (2013) Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
Douglas M. Coldwell, Martin Vyleta & Mahmood Samman. 2014. Liver Radioembolization with 90Y Microspheres. Liver Radioembolization with 90Y Microspheres
151
155
.
George C. Nikou & Theodoros P. Angelopoulos. (2012) Current Concepts on Gastric Carcinoid Tumors. Gastroenterology Research and Practice 2012, pages 1-8.
Crossref
Crossref